DIFFERENTIAL DIAGNOSIS OF HEMORRHAGIC AND ISCHEMIC STROKE, WAYS TO OPTIMIZE REHABILITATION MEASURES
##plugins.themes.academic_pro.article.sidebar##
Downloads
##plugins.themes.academic_pro.article.main##
Abstract
Difficulties in the diagnosis of cerebral strokes can be divided into at least two main groups: topical diagnosis of a focus formed as a result of acute cerebrovascular accident (ACVI), and diagnosis of the nature of ACVA. It is important to note that if errors in the first group, as a rule, are minimal or insignificantly affect the tactics of treatment and the outcome of the disease, then errors in diagnosing the nature of stroke are dangerous by choosing the wrong treatment tactics and using contraindicated drugs, which may be one of the causes of death and the subject of lawsuits against doctors by the patient's relatives. Thus, the urgency of the problem of improving the diagnosis of the nature of stroke and, first of all, the difference between the ischemic nature of cerebral stroke (IMI) and hemorrhagic (HMI) in the acute period of the disease is obvious. This problem is of particular relevance now, when it has been proven that the use of new thrombolytic drugs (in the first 3 hours and earlier from the onset of the disease) can prevent the occurrence or significantly reduce the size of irreversible damage to the brain tissue in IMI, both atherothrombotic and thromboembolic
##plugins.themes.academic_pro.article.details##
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
- Kulikov A., Abdrashitova G. Budget Impact Analysis of Cerebrolysin In The Treatment of Acute Ischemic Stroke of Moderate and Severe Degrees of Severity In The Russian Federation. Value Health. 2015; 18 (7): A699. PMID: 26533918. DOI: 10.1016/j.jval.2015.09.2612.
- Ziganshina LE, Abakumova T, Vernay L. Cerebrolysin for acute ischaemic stroke. Cochrane Database Syst Rev. 2016; 12: CD007026 PMID: 27918088. DOI: 10.1002/14651858.CD007026.pub4.
- Handbook of Vidal. Medicinal preparations in Russia – 2017. Moscow: Vidal’ Rus Publ., 2017. 1240 p.
- Yasnetsov V.V., Prosvirova E.P., Tsublova E.G., et al. Comparative studies of antihypoxic, neuroprotective and analgesic action of succinatecontaining drugs. Aviakosmicheskaya i ekologicheskaya meditsina. 2012; 46 (6):41–45.
- Odinak M.M., Yanishevskiy S.N., Tsygan N.V., et al. The use of succinates for the correction of metabolic disorders in the penumbra in patients with stroke. Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(12–2: Stroke): 55–60.
- Ivanova GE, Shklovskii VM, Petrova EA. The principles of early rehabilitation of stroke patients. Kachestvo zhizni. Meditsina. 2006;2( 13):62-70.
- Skvortsova VI. Snizhenie zabolevaemosti, smertnosti i invalidnosti ot insul’tov v Rossiiskoi Federatsii. M.: Litterra; 2008.
- Fedin AI, Tyutyumova EA, Badalyan KR. Ischemic cascade in the acute period of the stroke and methods of its correction. Farmateka. 2017;9:99-104.
- Khasanova DR, Gavrilov IA, Prokofeva IuV, Kamalov IR. The introduction of the multilevel system of medical care for stroke patients in the Tatarstan Republic. Zhurnal nevrologii ipsikhiatrii im. S.S. Korsakova. 2014;114:8(2):74-79.
- Fedin AI. Klinicheskie aspekty patogeneticheskoi terapii ishemii go- lovnogo mozga. Minimizatsiya negativnogoprognoza. M.: OOO «AST»; 2016.
- Voronina TA. The pioneer of antioxidant neuroprotection. 20 years in clinical practice. RMJ. 2016;24(7):434-438.
- Shulkin AV. Mexidol influence on the development of the phenomen of neurons excitotoxicity in vitro. Zhurnal nevrologii ipsikhiatrii im. S.S. Korsakova. 2012;112(2):35-39.